November 13, 2007
GENELABS TECHNOLOGIES, INC. REPORTS FINANCIAL RESULTS FOR THE THIRD QUARTER AND FIRST NINE MONTHS OF 2007

November 5, 2007
GENELABS TECHNOLOGIES TO PRESENT AT THE ACUMEN BIOFIN RODMAN & RENSHAW 9TH ANNUAL HEALTHCARE CONFERENCE

October 30, 2007
GENELABS TECHNOLOGIES ANNOUNCES APPOINTMENT OF FREDERICK W. DRISCOLL AS CHIEF FINANCIAL OFFICER

October 1, 2007
Genelabs Technologies Announces Completion of $23.7 Million Registered Direct Financing

September 26, 2007
Genelabs Technologies Announces Commitments to Raise $23.7 Million in a Registered Direct Financing

August 13, 2007
GENELABS TECHNOLOGIES, INC. REPORTS FINANCIAL RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF 2007

May 14, 2007
GENELABS TECHNOLOGIES, INC. REPORTS FIRST QUARTER 2007 FINANCIAL RESULTS

May 2, 2007
Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV Polymerase Inhibitor at 20th International Conference on Antiviral Research Meeting

April 23, 2007
GENELABS TECHNOLOGIES ANNOUNCES APPOINTMENT OF LESLIE J. BROWNE AND MATTHEW J. PFEFFER TO ITS BOARD OF DIRECTORS

April 2, 2007
Genelabs Technologies Receives Agreement from FDA on Special Protocol Assessment for Phase III Trial of Prestara in Lupus

March 22, 2007
GENELABS TECHNOLOGIES REPORTS 2006 YEAR-END AND FOURTH QUARTER FINANCIAL RESULTS

March 1, 2007
Genelabs Announces Publication in New England Journal of Medicine of Clinical Trial Results with Hepatitis E Virus Vaccine

February 14, 2007
Genelabs Technologies Announces Completion of $10 Million Private Placement Financing

February 8, 2007
Genelabs Technologies Announces Agreement to Raise $10 Million in Private Placement Financing

January 29, 2007
Genelabs Technologies Announces Sale of Equity in Taiwan-Based Biotechnology Company

© Genelabs Technologies, Inc. All rights reserved. - Terms of Use